HomeFUNDING

FUNDING

Orpyx® Medical Technologies Secures $7.6M in Series A Funding

Paddock Capital Inc. led the investment round with participation from existing and new investors.

Polares Medical Closes a $40M Financing

Jacques Essinger, Ph.D., Chairman and CEO, said, "With this Series B financing, we intend to advance our clinical studies in Europe and the United States.”

Affluent Medical Announces €15.8 Million in New Financing

The investment was led by Truffle Capital through the Truffle Biomedtech FCPI Fund and Truffle Innov FRR France and other investors

Okami Medical Announces Closing of $7.2M Series D Financing

The financing provides Okami, the second portfolio company of medical device incubator Inceptus Medical LLC, with capital to commercialize its innovative catheter-based technologies for peripheral vascular occlusion.

Cloud DX Awarded $1.75 Million from NGen Supercluster to Create Advanced Medical Device Centre in Ontario

The Cloud DX Connected Health platform gives doctors the automated monitoring ability they need to send many non-acute patients home sooner, freeing up beds, and relieving pressure on front line staff.

Carlsmed Raises $2.5M to Improve Complex Spine Surgery

The round was led by Cove Fund II, a prominent California Life Science and Technology fund. Participating in the round are MedTech funds Wavemaker Three-Sixty Health and Device of Tomorrow Capital, as well as individual MedTech investors.

Foldax Closes $20 Million Financing

MemorialCare Innovation Fund led the round, with Angel Physicians Fund and Sayan Bioventures joining as new investors.

Puzzle Medical Devices Inc. Announces the Closing of a First Financing Round: Funds to Support Clinical Testing of the Transcatheter Pump

"The accomplishments achieved by Puzzle Medical Devices Inc. in such a short period of time are remarkable," stated Pascal Labrecque. "It already has international support from pioneering interventional cardiologists, on top of an ever-growing IP portfolio. We are enthusiastic about its competent team and bright future."

GlySens Incorporated Closes Incremental $15 Million Financing

Proceeds from the financing will support ongoing clinical trials and development programs supporting the Company's fully implanted, long-term CGM systems and additionally, enable first-in-man studies of the third-generation system.